{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:53:12Z","timestamp":1791841992228,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/14414-8"],"award-info":[{"award-number":["2021\/14414-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/15175-1"],"award-info":[{"award-number":["2017\/15175-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/16805-4"],"award-info":[{"award-number":["2019\/16805-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303839\/2019-8"],"award-info":[{"award-number":["303839\/2019-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00210-023-02805-x","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T04:02:31Z","timestamp":1698811351000},"page":"3227-3238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alpha1-adrenergic blockers selectively antagonize the contractions induced by 6-nitrodopamine in the human vas deferens"],"prefix":"10.1007","volume":"397","author":[{"given":"Jos\u00e9","family":"Britto-J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Arthur Bosio","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis Lima","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Tiago","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Quirino Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Augusto","family":"de Oliveira Stocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson Hiroshi","family":"Salgado Uramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fregonesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"De Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"2805_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0361-9230(82)90172-1","volume":"9","author":"P Alm","year":"1982","unstructured":"Alm P (1982) On the autonomic innervation of the human vas deferens. Brain Res Bull 9:673\u2013677. https:\/\/doi.org\/10.1016\/0361-9230(82)90172-1","journal-title":"Brain Res Bull"},{"key":"2805_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.fertnstert.2015.08.033","volume":"104","author":"A Alwaal","year":"2015","unstructured":"Alwaal A, Breyer BN, Lue TF (2015) Normal male sexual function: emphasis on orgasm and ejaculation. Fertil Steril 104:1051\u20131060. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.08.033","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"2805_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1464-410x.2000.00059.x","volume":"85","author":"KE Andersson","year":"2000","unstructured":"Andersson KE (2000) Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms. BJU Int 85(Suppl 2):12\u201318. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00059.x","journal-title":"BJU Int"},{"key":"2805_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00496704","volume":"90","author":"HG Baumgarten","year":"1968","unstructured":"Baumgarten HG, Falck B, Holstein AF, Owman C, Owman T (1968) Adrenergic innervation of the human testis, epididymis, ductus deferens and prostate: a fluorescence microscopic and fluorimetric study. Z Zellforsch Mikrosk Anat 90:81\u201395. https:\/\/doi.org\/10.1007\/BF00496704","journal-title":"Z Zellforsch Mikrosk Anat"},{"issue":"276","key":"2805_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119425","volume":"1","author":"J Britto-J\u00fanior","year":"2021","unstructured":"Britto-J\u00fanior J, Coelho-Silva WC, Murari GF, Serpellone Nash CE, M\u00f3nica FZ, Antunes E, De Nucci G (2021a) 6-Nitrodopamine is released by human umbilical cord vessels and modulates vascular reactivity. Life Sci 1(276):119425. https:\/\/doi.org\/10.1016\/j.lfs.2021.119425","journal-title":"Life Sci"},{"issue":"911","key":"2805_CR6","doi-asserted-by":"publisher","first-page":"174544","DOI":"10.1016\/j.ejphar.2021.174544","volume":"15","author":"J Britto-J\u00fanior","year":"2021","unstructured":"Britto-J\u00fanior J, Ximenes L, Ribeiro A, Fregonesi A, Campos R, Ricardo de Almeida Kiguti L, M\u00f3nica FZ, Antunes E, De Nucci G (2021b) 6-Nitrodopamine is an endogenous mediator of rat isolated epididymal vas deferens contractions induced by electric-field stimulation. Eur J Pharmacol. 15(911):174544. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174544","journal-title":"Eur J Pharmacol."},{"key":"2805_CR7","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/andr.13263","volume":"10","author":"J Britto-J\u00fanior","year":"2022","unstructured":"Britto-J\u00fanior J, da Silva-Filho WP, Amorim AC, Campos R, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G (2022a) 6-nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology 10:1540\u20131547. https:\/\/doi.org\/10.1111\/andr.13263","journal-title":"Andrology"},{"issue":"915","key":"2805_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174716","volume":"15","author":"J Britto-J\u00fanior","year":"2022","unstructured":"Britto-J\u00fanior J, Ribeiro A, Ximenes L, Lima AT, Jacintho FF, Fregonesi A, M\u00f3nica FZ, Antunes E, De Nucci G (2022b) Alpha1-adrenergic antagonists block 6-nitrodopamine contractions on the rat isolated epididymal vas deferens. Eur J Pharmacol 15(915):174716. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174716","journal-title":"Eur J Pharmacol"},{"key":"2805_CR9","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s00210-023-02478-6","volume":"396","author":"J Britto-J\u00fanior","year":"2023","unstructured":"Britto-J\u00fanior J, Lima AT, Campos R, Gi\u00e3o AA, Mendes GD, Ferreira-Novaes Silva LP, Fregonesi A, Pupo AS, Antunes E, De Nucci G (2023a) 6-Nitrodopamine potentiates contractions of rat isolated vas deferens induced by noradrenaline, adrenaline, dopamine and electric field stimulation. Naunyn Schmiedebergs Arch Pharmacol 396:2555\u20132570. https:\/\/doi.org\/10.1007\/s00210-023-02478-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2805_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00210-023-02394-9","volume":"396","author":"J Britto-J\u00fanior","year":"2023","unstructured":"Britto-J\u00fanior J, Lima AT, Fuguhara V, Monica FZ, Antunes E, De Nucci G (2023b) Investigation on the positive chronotropic action of 6-nitrodopamine in the rat isolated atria. Naunyn Schmiedebergs Arch Pharmacol 396:1279\u20131290. https:\/\/doi.org\/10.1007\/s00210-023-02394-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"22","key":"2805_CR11","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1016\/j.bmcl.2007.09.051","volume":"17","author":"G Chiu","year":"2007","unstructured":"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA (2007) Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a\/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia\/lower urinary tract symptoms (BPH\/LUTS). Bioorg Med Chem Lett 17(22):6123\u20136128. https:\/\/doi.org\/10.1016\/j.bmcl.2007.09.051","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"2805_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/RRU.S41618","volume":"26","author":"HJ Cho","year":"2014","unstructured":"Cho HJ, Yoo TK (2014) Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability. Res Rep Urol 26(6):113\u2013119. https:\/\/doi.org\/10.2147\/RRU.S41618","journal-title":"Res Rep Urol"},{"key":"2805_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s11255-012-0261-6","volume":"44","author":"Y Cui","year":"2012","unstructured":"Cui Y, Zong H, Zhang Y (2012) The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis. Int Urol Nephrol 44:1601\u20131609. https:\/\/doi.org\/10.1007\/s11255-012-0261-6","journal-title":"Int Urol Nephrol"},{"issue":"5 Suppl 1","key":"2805_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/s0090-4295(00)00744-5","volume":"1;56","author":"FM Debruyne","year":"2000","unstructured":"Debruyne FM (2000) Alpha blockers: are all created equal? Urology 1;56(5 Suppl 1):20\u20132. https:\/\/doi.org\/10.1016\/s0090-4295(00)00744-5","journal-title":"Urology"},{"issue":"3\u20134","key":"2805_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/aap.12015","volume":"33","author":"JR Docherty","year":"2013","unstructured":"Docherty JR (2013) Prazosin has low potency at \u03b11A-adrenoceptors and high potency at \u03b11D -adrenoceptors in rat vas deferens. Auton Autacoid Pharmacol 33(3\u20134):49\u201357. https:\/\/doi.org\/10.1111\/aap.12015","journal-title":"Auton Autacoid Pharmacol"},{"key":"2805_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/00002512-200219020-00004","volume":"19","author":"CJ Dunn","year":"2002","unstructured":"Dunn CJ, Matheson A, Faulds DM (2002) Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging 19:135\u2013161. https:\/\/doi.org\/10.2165\/00002512-200219020-00004","journal-title":"Drugs Aging"},{"key":"2805_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2125.1982.tb01439.x","volume":"13","author":"HL Elliott","year":"1982","unstructured":"Elliott HL, Meredith PA, Sumner DJ, McLean K, Reid JL (1982) A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol 13:699\u2013703. https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb01439.x","journal-title":"Br J Clin Pharmacol"},{"key":"2805_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0025-7125(16)30778-7","volume":"72","author":"WH Frishman","year":"1988","unstructured":"Frishman WH, Eisen G, Lapsker J (1988) Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension. Med Clin North Am 72:441\u2013448. https:\/\/doi.org\/10.1016\/s0025-7125(16)30778-7","journal-title":"Med Clin North Am"},{"key":"2805_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41585-022-00639-5","volume":"19","author":"M Gul","year":"2022","unstructured":"Gul M, Bocu K, Serefoglu EC (2022) Current and emerging treatment options for premature ejaculation. Nat Rev Urol 19:659\u2013680. https:\/\/doi.org\/10.1038\/s41585-022-00639-5","journal-title":"Nat Rev Urol"},{"issue":"1\u20132","key":"2805_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0014-2999(96)00502-x","volume":"313","author":"A Hatano","year":"1996","unstructured":"Hatano A, Tang R, Walden PD, Lepor H (1996) The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate. Eur J Pharmacol 313(1\u20132):135\u2013143. https:\/\/doi.org\/10.1016\/0014-2999(96)00502-x","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"2805_CR21","first-page":"874","volume":"173","author":"WJ Hellstrom","year":"2005","unstructured":"Hellstrom WJ, Smith W, Sikka SC (2005) Effects of alpha-blockers on ejaculatory function in normal subjects [abstract]. J Urol 173(Suppl):874","journal-title":"J Urol"},{"issue":"6","key":"2805_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/(SICI)1097-0029(19980915)42:6<409::AID-JEMT4>3.0.CO;2-H","volume":"42","author":"J Kaleczyc","year":"1998","unstructured":"Kaleczyc J (1998) Origin and neurochemical characteristics of nerve fibres supplying the mammalian vas deferens. Microsc Res Tech 42(6):409\u2013422. https:\/\/doi.org\/10.1002\/(SICI)1097-0029(19980915)42:6%3c409::AID-JEMT4%3e3.0.CO;2-H","journal-title":"Microsc Res Tech"},{"key":"2805_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1476-5381.1988.tb16557.x","volume":"95","author":"H Lepor","year":"1988","unstructured":"Lepor H, Baumann M, Shapiro E (1988) The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate. Br J Pharmacol 95:139\u2013144. https:\/\/doi.org\/10.1111\/j.1476-5381.1988.tb16557.x","journal-title":"Br J Pharmacol"},{"key":"2805_CR24","doi-asserted-by":"publisher","unstructured":"Lima AT, Amorim AC, Britto-J\u00fanior J, Campitelli RR, Fregonesi A, M\u00f3nica FZ, Antunes E, De Nucci G (2022) \u03b21- and \u03b21\/\u03b22-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens. Naunyn Schmiedebergs Arch Pharmacol 395(10):1257\u20131268. https:\/\/doi.org\/10.1007\/s00210-022-02268-6","DOI":"10.1007\/s00210-022-02268-6"},{"key":"2805_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.bjp.0707369","volume":"152","author":"MC Michel","year":"2007","unstructured":"Michel MC (2007) Alpha1-adrenoceptors and ejaculatory function. Br J Pharmacol 152:289\u2013290. https:\/\/doi.org\/10.1038\/sj.bjp.0707369","journal-title":"Br J Pharmacol"},{"key":"2805_CR26","first-page":"203","volume-title":"Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking","author":"H Motulsky","year":"2014","unstructured":"Motulsky H (2014) Normality Tests. Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking. Oxford University Press, New York, NY, pp 203\u2013208"},{"issue":"6 Suppl 1","key":"2805_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s0090-4295(01)01346-2","volume":"58","author":"MP O'Leary","year":"2001","unstructured":"O\u2019Leary MP (2001) Tamsulosin: current clinical experience. Urology 58(6 Suppl 1):42\u20138. https:\/\/doi.org\/10.1016\/s0090-4295(01)01346-2. (discussion 48)","journal-title":"Urology"},{"issue":"326","key":"2805_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121801","volume":"1","author":"LFG Oliveira","year":"2023","unstructured":"Oliveira LFG, Britto-J\u00fanior J, Lima AT, Moraes MO, Moraes MEA, de Souza VB, Schenka AA, Zakia Monica F, De Nucci G (2023) Release of 6-nitrodopamine from human popliteal artery and vein. Life Sci 1(326):121801. https:\/\/doi.org\/10.1016\/j.lfs.2023.121801","journal-title":"Life Sci"},{"issue":"66","key":"2805_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00344342","volume":"8","author":"C Owman","year":"1965","unstructured":"Owman C, Sjoestrand NO (1965) Short adrenergic neurons and catecholamine-containing cells in vas deferens and accessory male genital glands of different mammals. Z Zellforsch Mikrosk Anat 8(66):300\u2013320. https:\/\/doi.org\/10.1007\/BF00344342","journal-title":"Z Zellforsch Mikrosk Anat"},{"key":"2805_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1464-410x.1985.tb07026.x","volume":"57","author":"JW Ramsay","year":"1988","unstructured":"Ramsay JW, Scott GI, Whitfield HN (1988) A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction. Br J Urol 57:657\u2013659. https:\/\/doi.org\/10.1111\/j.1464-410x.1985.tb07026.x","journal-title":"Br J Urol"},{"key":"2805_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.ju.0000097026.43866.cc","volume":"171","author":"CG Roehrborn","year":"2004","unstructured":"Roehrborn CG, Schwinn DA (2004) Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 171:1029\u20131035. https:\/\/doi.org\/10.1097\/01.ju.0000097026.43866.cc","journal-title":"J Urol"},{"key":"2805_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ucl.2013.07.009","volume":"40","author":"MD Rogers","year":"2013","unstructured":"Rogers MD, Kolettis PN (2013) Vasectomy. Urol Clin North Am 40:559\u2013568","journal-title":"Urol Clin North Am"},{"key":"2805_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.bjp.0707366","volume":"152","author":"A Sanbe","year":"2007","unstructured":"Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A (2007) Alpha1-adrenoceptors are required for normal male sexual function. Br J Pharmacol 152:332\u2013340. https:\/\/doi.org\/10.1038\/sj.bjp.0707366","journal-title":"Br J Pharmacol"},{"key":"2805_CR34","first-page":"250","volume":"48","author":"K Shibata","year":"1995","unstructured":"Shibata K, Foglar R, Horie K, Obika K, Sakamoto A, Ogawa S, Tsujimoto G (1995) KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 48:250\u2013258","journal-title":"Mol Pharmacol"},{"key":"2805_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1248\/yakushi.126.209","volume":"12","author":"S Tatemichi","year":"2006","unstructured":"Tatemichi S, Kobayashi K, Maezawa A, Kobayashi M, Yamazaki Y, Shibata N (2006) Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213). Yakugaku Zasshi. 12:209\u201316. https:\/\/doi.org\/10.1248\/yakushi.126.209. (Japanese)","journal-title":"Yakugaku Zasshi."},{"issue":"50","key":"2805_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-2999(78)90258-3","volume":"1","author":"DC U'Prichard","year":"1978","unstructured":"U\u2019Prichard DC, Charness ME, Robertson D, Snyder SH (1978) Prazosin: differential affinities for two populations of alpha-noradrenergic receptor binding sites. Eur J Pharmacol 1(50):87\u201389. https:\/\/doi.org\/10.1016\/0014-2999(78)90258-3","journal-title":"Eur J Pharmacol"},{"key":"2805_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003495-200666030-00002","volume":"66","author":"MM van Dijk","year":"2006","unstructured":"van Dijk MM, de la Rosette JJ, Michel MC (2006) Effects of alpha(1)- adrenoceptor antagonists on male sexual function. Drugs 66:287\u2013301","journal-title":"Drugs"},{"issue":"1","key":"2805_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/jpet.302.1.58","volume":"302","author":"A Vicentic","year":"2002","unstructured":"Vicentic A, Robeva A, Rogge G, Uberti M, Minneman KP (2002) Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. J Pharmacol Exp Ther 302(1):58\u201365. https:\/\/doi.org\/10.1124\/jpet.302.1.58","journal-title":"J Pharmacol Exp Ther"},{"key":"2805_CR39","doi-asserted-by":"publisher","first-page":"635\u00b140","DOI":"10.1016\/S0022-5347(01)61986-4","volume":"161","author":"PD Walden","year":"1999","unstructured":"Walden PD, Gerardi C, Lepor H (1999) Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161:635\u00b140","journal-title":"J Urol"},{"key":"2805_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/ciia.2006.1.4.389","volume":"1","author":"TJ Wilt","year":"2006","unstructured":"Wilt TJ, MacDonald R (2006) Doxazosin in the treatment of benign prostatic hypertrophy: an update. Clin Interv Aging 1:389\u2013401. https:\/\/doi.org\/10.2147\/ciia.2006.1.4.389","journal-title":"Clin Interv Aging"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02805-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T06:12:09Z","timestamp":1714975929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02805-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2805"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02805-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3381934\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation followed the principles outlined in the Declaration of Helsinki and the protocol was approved by the Ethics Committee of the Institute of Biomedical Sciences of the University of S\u00e3o Paulo \u2013 ICB\/USP (protocol number 4.468.508), and the patients were asked to sign an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors authorize the submission and publication of this article in <i>Naunyn\u2013Schmiedeberg's Archives of Pharmacology.<\/i>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}